What question did this study set out to answer?

This research explores the effectiveness of MRI-guided biopsy in detecting early-stage invasive carcinoma specifically in BRCA1/2 mutation carriers.

March 26, 2026Open Access

Clinicopathological Characteristics of Lesions Diagnosed by MRI-Guided Biopsy in BRCA1/2 Mutation Carriers

Key Points

This research explores the effectiveness of MRI-guided biopsy in detecting early-stage invasive carcinoma specifically in BRCA1/2 mutation carriers.
Utilized MRI-guided biopsy to assess lesions in BRCA1/2 carriers.
Focused on lesions categorized as breast imaging reporting and data system 3.
Highlighted the need for prospective studies to examine clinical outcomes.
MRI-guided biopsy effectively detected early-stage invasive carcinoma.
Emphasis on tailored surveillance strategies for BRCA1/2 carriers.
Calls for further validation through long-term clinical studies.

Abstract

MRI-guided biopsy was effective in detecting early-stage invasive carcinoma in BRCA1/2 carriers, highlighting its role in tailored surveillance strategies. For new lesions categorized as breast imaging reporting and data system 3 on MRI, biopsy should be considered, particularly for BRCA1/2 carriers. Prospective studies are needed to validate these findings and assess long-term clinical outcomes to inform personalized management approaches for high-risk populations.

Bookmark

View Full Paper

Cite This Study

Nagata et al. (Tue,) studied this question.

synapsesocial.com/papers/69c4cd98fdc3bde44891a39b https://doi.org/https://doi.org/10.4274/ejbh.galenos.2025.2025-5-8

Bookmark

View Full Paper